Publicaciones en las que colabora con Javier Arbizu Lostao (24)

2017

  1. Effective dose estimation for oncological and neurological PET/CT procedures

    EJNMMI Research, Vol. 7, Núm. 1

2015

  1. A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres: The QUEST Phantom Study

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 42, Núm. 8, pp. 1202-1222

  2. Brain PET imaging optimization with time of flight and point spread function modelling

    Physica Medica, Vol. 31, Núm. 8, pp. 948-955

2014

  1. Nuclear Medicine Procedures for Treatment Evaluation and Administration

    Liver Radioembolization with 90Y Microspheres (Springer-Verlag), pp. 63-75

  2. PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization

    Medical Physics, Vol. 41, Núm. 9

2013

  1. Aportación del tiempo de vuelo y de la modelización de la respuesta a una fuente puntual a las características de funcionamiento del tomógrafo PET/TAC Biograph mCT

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 32, Núm. 1, pp. 13-21

  2. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Núm. 9, pp. 1394-1405

2012

  1. Decreased carbon-11-flumazenil binding in early Alzheimer's disease

    Brain, Vol. 135, Núm. 9, pp. 2817-2825

  2. Quantitative volumetric analysis of gliomas with sequential MRI and 11C-methionine PET assessment: Patterns of integration in therapy planning

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, Núm. 5, pp. 771-781

2011

  1. Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation

    Journal of Nuclear Medicine, Vol. 52, Núm. 6, pp. 865-872

2010

  1. Brain glucose metabolism in vascular white matter disease with dementia: Differentiation from Alzheimer disease

    Stroke, Vol. 41, Núm. 12, pp. 2889-2893

  2. Evaluation of spatial resolution of a PET scanner through the simulation and experimental measurement of the recovery coefficient

    Computers in Biology and Medicine, Vol. 40, Núm. 1, pp. 75-80

  3. Neuroimagen: Fundamentos técnicos y prácticos

    Revista Espanola de Medicina Nuclear, Vol. 29, Núm. 4, pp. 189-210

  4. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An 18F-DOPA and 11C-DTBZ PET study

    Neurobiology of Disease, Vol. 38, Núm. 3, pp. 456-463

2009

  1. Cortical atrophy and language network reorganization associated with a novel progranulin mutation

    Cerebral Cortex, Vol. 19, Núm. 8, pp. 1751-1760

  2. New MRI, 18F-DOPA and 11C-(+)-α-dihydrotetrabenazine templates for Macaca fascicularis neuroimaging: Advantages to improve PET quantification

    NeuroImage, Vol. 47, Núm. 2, pp. 533-539

2008

  1. Síntesis rápida y simplificada de 11C-(+)-α- dihidrotetrabenazina para su utilización como radioligando PET de los transportadores vesiculares de monoaminas

    Revista Espanola de Medicina Nuclear, Vol. 27, Núm. 1, pp. 13-21

  2. Utilización de la11C-(+)-α-dihidrotetrabenazina para la evaluación de la inervación dopaminérgica en modelos animales de la enfermedad de Parkinson

    Revista Espanola de Medicina Nuclear, Vol. 27, Núm. 2, pp. 103-111

2006

  1. Simple automated system for simultaneous production of 11C-labeled tracers by solid supported methylation

    Applied Radiation and Isotopes, Vol. 64, Núm. 7, pp. 808-811

2002

  1. Activation of human cerebral and cerebellar cortex by auditory stimulation at 40 Hz

    Journal of Neuroscience, Vol. 22, Núm. 23, pp. 10501-10506